TAMPA, Fla. & MINNEAPOLIS--(BUSINESS WIRE)--Biovest International, Inc. (OTCQB:BVTI) today reported that the Company has filed a petition for protection under Chapter 11 of the U.S. Bankruptcy Code ...
Mark Hirschel, chief scientific officer of Biovest International Inc., said $1.5 million in renovations will create a clean room in the company’s 35,000-square-foot plant in Coon Rapids. (Staff photo: ...
TAMPA, Fla. & MINNEAPOLIS, May 18, 2010 (BUSINESS WIRE) -- Biovest International, Inc. (Pink Sheets: BVTI) today announced that it is under contract with the U.S. Department of Defense ("DoD") to ...
Biovest International is seeking marketing approval in Canada for BiovaxID, its personalized cancer vaccine for the treatment of follicular non-Hodgkin’s lymphoma, an incurable cancer of the immune ...
TAMPA, Fla. & MINNEAPOLIS--(BUSINESS WIRE)--Biovest International, Inc. (OTCQB: BVTI) today announced that the Company has entered into a research collaboration agreement with Ordway Research ...
Biovest International, Inc. (OTCQB:BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (OTCQB:ABPI), today announced that Biovest plans to file for marketing approval in the ...
Biovest International — a Tampa, Fla.-based cancer vaccine company with a Coon Rapids manufacturing plant — said Thursday that it has filed for Chapter 11 bankruptcy petition. The company is seeking ...
TAMPA, Fla & MINNEAPOLIS--(BUSINESS WIRE)--Biovest International, Inc. (OTCQB: BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (OTCQB: ABPI), today announced that the Naval ...
Accentia Biopharmaceuticals, Inc. (NASDAQ: ABPI) and its subsidiary, Biovest International, Inc. (OTCBB:BVTI), announces that it has made a formal amendment request to the FDA seeking to use pivotal ...
Biovest International Inc. (BVTI.PK) is a clinical stage biotech company focused on the research and development of therapeutic cancer vaccines and related business. It is a majority-owned subsidiary ...
TAMPA, Fla. & MINNEAPOLIS--(BUSINESS WIRE)--Biovest International, Inc. (OTCQB: BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (OTCQB: ABPI), today announced that Biovest and ...
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., plans to file a Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results